CYTOKINETICS INC — Director's Dealing 2018

Mar 1, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2018-02-27

Reporting Person: Blum Robert I (Director, President & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-02-27	Common Stock	A	100000	$0.001	Acquired	165680	Direct
2018-02-28	Common Stock	A	45000	$0.001	Acquired	210680	Direct
2018-02-28	Common Stock	F	15681	$7.75	Disposed	194999	Direct
2018-02-28	Common Stock	F	8298	$7.75	Disposed	186701	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-02-27	Incentive Stock Option (right to buy)	$7.8	A	9546	Acquired	2028-02-27	Common Stock (9546)	Direct
2018-02-27	Non-Qualified Stock Option (right to buy)	$7.8	A	190454	Acquired	2028-02-27	Common Stock (190454)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	2083	Indirect
Common Stock	2083	Indirect

Footnotes

F1: The restricted stock units vest in three annual installments. Vested shares will be delivered to the reporting person as follows: 40% on 02/27/2019, 40% on 02/27/2020 and 20% on 03/01/2021.

F2: Shares held by The Bridget Blum 2003 Irrevocable Trust.

F3: Shares held by The Brittany Blum 2003 Irrevocable Trust.

F4: When the ISO and NQ dated 02/27/2018 are combined, the total grant shall vest and become exercisable in equal monthly installments such that the option shall be 100% vested on 02/27/2022.